We have found in prior and recent studies that PLP-binding is important for the tumor-inhibitory function of Pfn1 (Diamond et al., 2015), at least partially due to the direct interaction of nuclear Pfn1 with ENL, a PLP-containing protein, in the SEC complex (Zhu et al., 2021). This evidence concerns the gene PFN1 and neoplasm.